自身免疫炎症性风湿病患者疫苗可预防感染发病率与患病率系统综述
结果显示AIIRD患者流感和肺炎球菌疾病发病率升高,带状疱疹合并发病率比为2.9(95%CI 2.4-3.3),其中炎性肌病最高(5.1,95%CI 4.3-5.9)。
要点
- AIIRD患者带状疱疹合并发病率比为2.9(95%CI 2.4-3.3),炎性肌病、SLE和RA风险依次升高。
- AIIRD患者流感和肺炎球菌疾病发病率升高,HPV感染合并患病比为1.6(95%CI 0.7-3.4)。
- AIIRD患者乙肝表面抗原和核心抗体合并患病率与一般人群相似。
核心结论
- 当前证据显示AIIRD患者疫苗可预防感染风险增加,强调预防感染在这些患者中至关重要。
主要发现
- AIIRD患者流感和肺炎球菌疾病发病率升高。
- AIIRD患者带状疱疹合并发病率比为2.9(95%CI 2.4-3.3),对比一般人群。
- 炎性肌病带状疱疹合并发病率比最高为5.1(95%CI 4.3-5.9),其次SLE为4.0(95%CI 2.3-5.7),RA为2.3(95%CI 2.1-2.6)。
- HPV感染合并患病比为1.6(95%CI 0.7-3.4),对比一般人群,主要基于拉丁美洲和亚洲SLE人群研究。
- AIIRD患者乙肝表面抗原合并患病率为3%(95%CI 1%-5%),乙肝核心抗体为15%(95%CI 7%-26%),与一般人群相似。
临床怎么用
- 临床应重视AIIRD患者的疫苗可预防感染预防,尤其针对流感和肺炎球菌疾病。
- 对炎性肌病、SLE和RA患者应特别关注带状疱疹风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aims of this study were to update the evidence on the incidence and prevalence rates of vaccine preventable infections (VPI) in patients with autoimmune inflammatory rheumatic diseases (AIIRD) and compare the data to the general population when available. METHODS: A literature search was performed using Medline, Embase and Cochrane library (October 2009 to August 2018). The primary outcome was the incidence or prevalence of VPI in the adult AIIRD population. Meta-analysis was performed when appropriate. RESULTS: Sixty-three publications out of 3876 identified records met the inclusion criteria: influenza (n=4), pneumococcal disease (n=7), hepatitis B (n=10), herpes zoster (HZ) (n=29), human papillomavirus (HPV) infection (n=13). An increased incidence of influenza and pneumococcal disease was reported in patients with AIIRD. HZ infection-pooled incidence rate ratio (IRR) was 2.9 (95% CI 2.4 to 3.3) in patients with AIIRD versus general population. Among AIIRD, inflammatory myositis conferred the highest incidence rate (IR) of HZ (pooled IRR 5.1, 95% CI 4.3 to 5.9), followed by systemic lupus erythematosus (SLE) (pooled IRR 4.0, 95% CI 2.3 to 5.7) and rheumatoid arthritis (pooled IRR 2.3, 95% CI 2.1 to 2.6). HPV infection-pooled prevalence ratio was 1.6, 95% CI 0.7 to 3.4 versus general population, based on studies mainly conducted in the SLE population in Latin America and Asia. Pooled prevalence of hepatitis B surface antigen and hepatitis B core antibody in patients with AIIRD was similar to the general population, 3%, 95% CI 1% to 5% and 15%, 95% CI 7% to 26%, respectively. CONCLUSION: Current evidence shows an increased risk of VPI in patients with AIIRD, emphasising that prevention of infections is essential in these patients.
引用
- Furer V, Rondaan C, Heijstek M, et al. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open. 2019. PMID: 31673420. doi:10.1136/rmdopen-2019-001041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。